Pre-market
Loading markets…

Advertisement

Stocks

What's Going On With Jack Nathan Medical Corp Stock Monday?

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:JNH.V

Follow JNH

Photos provided by Pexels

Jack Nathan Medical Corp's stock remains stagnant as company leadership faces significant changes.

This week, Jack Nathan Medical Corp (JNH.V) continues to see no movement in its stock price, closing at C$0.01. The company has recently undergone notable changes in its board and executive leadership, which may impact investor sentiment moving forward.

Advertisement

Jack Nathan Medical Corp

JNH.V

Full stock page →

JNH.V

Jack Nathan Medical Corp

Source:WealthAwesomeWealthAwesome
↑ $0.00 (0.00%)
120 day period
$0.01$0.51$0.01Jan 8Apr 14Oct 2

Market cap

$870,991

52W high

$0.01

52W low

$0.01

1W change

+0.00%

Beta

-0.31

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on JNH's historical volatility

HistoricalForecast68%95%
C$0.01C$0.01C$0.01C$0.01C$0.01C$0.01TodayFeb 27May 5Oct 2Nov 14Dec 28Feb 9

30-Day Vol

0.0%

Annualized

90-Day Vol

0.0%

Annualized

Trend (90d)

+0.0%

Annualized drift

90d Mean

C$0.01

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.01C$0.01 – C$0.01
60 trading daysC$0.01C$0.01 – C$0.01
90 trading daysC$0.01C$0.01 – C$0.01

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: Investors should remain cautious as the company navigates leadership transitions amidst ongoing operational adjustments.

Jack Nathan Medical Corp maintains a market cap of C$870,991.

Despite a market cap under C$1 million, the company's profit margin remains at 0.0%, reflecting challenges in achieving profitability.

Bull case

The recent leadership changes could indicate a new direction for the company. This shift might open doors to strategic partnerships or investments that could benefit shareholders in the long run.

Bear case

Ongoing issues with corporate governance and the absence of positive news could undermine investor confidence, especially considering the company's past performance and current market cap.

Price Action Overview

Jack Nathan Medical Corp (JNH.V) has had a stagnant week, with no change in its stock price, closing at C$0.01. The performance metrics show a flat trajectory, with no significant gains or losses observed over the past month or year-to-date.

Recent Company News

Advertisement

Recent headlines surrounding Jack Nathan Medical Corp include significant board resignations and a leadership transition. On July 31, 2026, the company announced the resignations of Chairman Blake Lyon and Director Anthony DeCristofaro. Additionally, CEO Mike Marchelletta stepped down in January 2026 to lead a prospective investor syndicate, with Michael Di Cesare appointed as Interim CEO. These changes may indicate a shift in strategic direction as the company evaluates potential partnerships.

Technical Picture

From a technical perspective, Jack Nathan Medical Corp's stock is trading at its 50-day and 200-day moving averages of C$0.01, indicating a lack of momentum in either direction. The stock has a beta of -0.19, suggesting lower volatility compared to the overall market. With a market cap of approximately C$870,991, the company operates in a challenging environment, reflected in its 0.0% profit margin and a return on equity (ROE) of -1961.6%.

Insider Activity

No recent insider activity has been reported for Jack Nathan Medical Corp, which may be noteworthy for investors monitoring potential insider confidence in the company's future.

Conclusion

As of the latest close, Jack Nathan Medical Corp stands at C$0.01, with no percentage change noted for the day. Investors should closely monitor the company's strategic direction following recent leadership changes and assess how these developments may influence future performance.

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: September 14, 2026
Last Updated: October 2, 2026

Core portfolio

Awesome Portfolio™

14.8% a year since 2017, against 9.7% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+14.8%

Awesome Portfolio™

+9.7%

S&P/TSX

+5.0 pp better a year

Total return

+254%

Awesome Portfolio™

+134%

S&P/TSX

+119 pp better than the TSX

2017-07-31 to 2026-09-29, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-29
-11.7%42.5%96.7%150.9%205.1%259.3%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement